SEARCH · PubMed Health

Results for “Particle Accelerators”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,675 records · Page 93Linked to original sources

PubMed2004

Induced radioactivity in CU targets produced by high-energy heavy ions and the corresponding estimated photon dose rates.

Irradiation experiments were performed at the Heavy Ion Medical Accelerator in Chiba (HIMAC) facility, National Institute of Radiological Sciences. The radioactive spallation products in a thick Cu target were obtained for Ar(230, 400 MeV per nucleon), Si(800 MeV per nucleon), Ne(100, 230, 400 MeV per nucleon), C(100, 230, 400 MeV per nucleon), He(100, 230 MeV per nucleon), p(100, 230 MeV) ions. The gamma-ray spectra from irradiated Cu samples inserted into the composite Cu target were measured with a high-purity germanium (HPGe) detector. From the gamma-ray spectra, we obtained the spatial distribution of radioactive yields of spallation products of 40 nuclides in the Cu sample in the Cu target. From the spatial distribution of radioactive yields, we estimated the residual activity and photon dose induced in the Cu target. The residual activity and photon dose become larger with the increase in projectile energy per nucleon and the range of the projectile beam for the same projectile energy per nucleon.

Copper↗

PubMed1998

Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides.

PURPOSE: The purpose of this report is to discuss the utilization of thermoluminescent dosimetry (TLD) in total skin electron beam (TSEB) radiotherapy to: (a) compare patient dose distributions for similar techniques on different machines, (b) confirm beam calibration and monitor unit calculations, (c) provide data for making clinical decisions, and (d) study reasons for variations in individual dose readings. METHODS AND MATERIALS: We report dosimetric results for 72 cases of mycosis fungoides, using similar irradiation techniques on two different linear accelerators. All patients were treated using a modified Stanford 6-field technique. In vivo TLD was done on all patients, and the data for all patients treated on both machines was collected into a database for analysis. Means and standard deviations (SDs) were computed for all locations. Scatter plots of doses vs. height, weight, and obesity index were generated, and correlation coefficients with these variables were computed. RESULTS: The TLD results show that our current TSEB implementation is dosimetrically equivalent to the previous implementation, and that our beam calibration technique and monitor unit calculation is accurate. Correlations with obesity index were significant at several sites. Individual TLD results allow us to customize the boost treatment for each patient, in addition to revealing patient positioning problems and/or systematic variations in dose caused by patient variability. The data agree well with previously published TLD results for similar TSEB techniques. CONCLUSION: TLD is an important part of the treatment planning and quality assurance programs for TSEB, and routine use of TLD measurements for TSEB is recommended.

Electrons↗

PubMed2004

Calibration of low-energy electron beams from a mobile linear accelerator with plane-parallel chambers using both TG-51 and TG-21 protocols.

A new approach to intraoperative radiation therapy led to the development of mobile linear electron accelerators that provide lower electron energy beams than the usual conventional accelerators commonly encountered in radiotherapy. Such mobile electron accelerators produce electron beams that have nominal energies of 4, 6, 9 and 12 MeV. This work compares the absorbed dose output calibrations using both the AAPM TG-51 and TG-21 dose calibration protocols for two types of ion chambers: a plane-parallel (PP) ionization chamber and a cylindrical ionization chamber. Our results indicate that the use of a 'Markus' PP chamber causes 2-3% overestimation in dose-output determination if accredited dosimetry-calibration laboratory based chamber factors (N(60Co)(D,w,) Nx) are used. However, if the ionization chamber factors are derived using a cross-comparison at a high-energy electron beam, then a good agreement is obtained (within 1%) with a calibrated cylindrical chamber over the entire energy range down to 4 MeV. Furthermore, even though the TG-51 does not recommend using cylindrical chambers at the low energies, our results show that the cylindrical chamber has a good agreement with the PP chamber not only at 6 MeV but also down to 4 MeV electron beams.

Calibration↗

PubMedDate not supplied

Superheated drop detector for determination of neutron dose equivalent to patients undergoing high-energy x-ray and electron radiotherapy.

The superheated drop detector (SDD) consists of thousands of superheated drops dispersed in a small vial of gel, which vaporize upon exposure to high LET radiation, thereby providing a directly observable indication of neutron dose. This detector possesses high sensitivity to neutrons and insensitivity to high-energy photons and electrons, making it suitable for the determination of neutron dose equivalent rates around high-energy photon and electron radiotherapy beams. In the present work, the SDD was used to measure the neutron dose equivalent in and around the radiotherapy beams produced by a 32-MeV linear accelerator. For both x-ray and electron beams, the neutron dose profiles were observed to follow the photon/electron radiotherapy beam profiles. For 25-MV x rays, the neutron dose equivalent per photon dose on the central axis increased by a factor of about 3 as field size increased from 5 x 5 to 30 x 30 cm. However, the neutron dose equivalent rate at 50 cm off-axis in the patient plane was essentially independent of field size. The neutron dose equivalent per electron dose was essentially zero for electron beams with energies below 15 MeV, but increased rapidly above 15 MeV. For 25-MeV electrons, neutron dose equivalent on the central axis was about 1/5 that for 25-MV x rays. Analogous to the data for 25-MV x rays, the neutron dose equivalent rate on the central axis of a 25-MeV electron beam exhibited a similar field size dependence and outside the beam it was essentially independent of field size.(ABSTRACT TRUNCATED AT 250 WORDS)

Electrons↗

PubMedDate not supplied

[Intraoperative radiotherapy with accelerated electrons for urinary bladder carcinoma: principles and results].

OBJECTIVE: To describe intraoperative radiotherapy with accelerated electrons, a highly selective method of administering irradiation for radical treatment of bladder cancer. METHODS: We reviewed the experience reported in the literature since this treatment modality was utilized in Japan and its application extended to the western countries. RESULTS: Animal experiments have shown an acceptable clinicopathological tolerance to 20 Gy intraoperative irradiation of partial bladder volume. The local recurrence rate was 9% for early solitary tumor (> T2) and 27% for early multicentric tumor, according to the Japanese clinical experience. In the western countries, intraoperative radiotherapy plus external irradiation with or without systemic chemotherapy achieves a pT0 of about 65% (in total cystectomy specimens) and an intravesical tumor control rate of 88% in organ-sparing protocols. CONCLUSIONS: The results achieved by the groups with wider experience demonstrate that highly selective intraoperative radiotherapy is feasible, well-tolerated and effective in terms of inducing complete pathological remissions and definitive control of intravesical tumor. These selected clinical experiences must be corroborated by multicenter studies.

Electrons↗

PubMed1983

Heavy ion action on yeast cells: inhibition of ribosomal-RNA synthesis, loss of colony forming ability and induction of mutants.

The action of heavy ions (Ar to U) accelerated to specific energies up to about 10 MeV/u (u=atomic mass unit) on different functions of yeast cells was studied. Ribosomal-RNA synthesis is inhibited according to a single-hit mechanism. Inactivation cross-sections were linearly related to the ratio of the squares of the effective charge Z* and the velocity of the ions. It is concluded from the analysis that the range of the most energetic delta-electrons is larger than previously assumed. There is no such dependence for survival and induction of mutants. In both cases cross-sections increase with the ion's specific-energy indicating an important contribution of long-range delta-electrons. The analysis shows that diploid yeast is not killed by a single-hit mechanism even by very heavy ions if the track width is too small. The relative importance of the penumbral region is even more pronounced with the more sensitive strains.

Argon↗

PubMed2001

Application of a test package in an intercomparison of the photon dose calculation performance of treatment planning systems used in a clinical setting.

BACKGROUND AND PURPOSE: Testing the performance of treatment planning systems by using the AAPM Task Group 23 test package is a useful approach, but has its limitations. To be able to include technical developments, such as the asymmetric collimator, it was decided to remeasure the AAPM data set on more modern radiotherapy equipment, to extend the test geometries, and to evaluate the use of the new package. MATERIALS AND METHODS: A coherent set of beam data of 6, 10 and 18 MV photon beams was measured on two modern linear accelerators. These data served as input data in seven commercially available treatment planning systems, which were clinically in use in different radiotherapy departments. Next, a test package was measured which included a missing tissue geometry and fields with asymmetrical collimator setting, with and without a wedge. RESULTS: The absolute dose prediction from the different treatment planning systems in which the measured beam data were entered, was compared for all test points with the results of direct measurements. The criteria of acceptability were exceeded by some systems in cases of irregular field geometry and missing tissue geometry. The majority of the systems had difficulties with accurate dose calculation for asymmetrically wedged fields. CONCLUSIONS: The application of the new test package did not introduce insuperable difficulties and was highly appreciated by the participating centres. Most systems performed reasonably well for the majority of the beam geometries, with the exception of asymmetrically wedged beams. The extended test package is available for other users or user groups for the purpose of commissioning new treatment planning systems, or new releases of existing systems.

Algorithms↗

PubMed1998

A commercial IMRT treatment-planning dose-calculation algorithm.

PURPOSE: The dose-calculation algorithm for a commercial arc-based intensity modulated radiation therapy (IMRT) treatment-planning and delivery system (Peacock, NOMOS Corporation) is described. METHODS AND MATERIALS: The IMRT delivery system uses a dynamically controlled multileaf collimator with 40 leaves that project on our accelerator to either 1.0 x 0.84 cm2 or 1.0 x 1.68 cm2 at isocenter arranged in two banks of 20 leaves each. The dose-calculation algorithm uses tissue-phantom ratios derived from percent depth dose measurements, measured relative output data, and single leaf profiles. Some compromises are made in the algorithm terms to enable more straightforward dosimetry measurements and to reduce dose computation times. The dose calculation algorithm is presented, and consequences of the approximations are investigated using previously published 4 MV photon beam data. RESULTS: Most of the approximations lead to dose errors of a few percent. However, the use of depth-invariant single-leaf profiles results in errors as large as 9% for 4 MV fixed beams. CONCLUSIONS: Large dosimetric errors are possible for small fixed fields using this algorithm. However, the algorithm is designed for tomotherapy dose delivery, where doses are delivered from multiple directions and depths. Investigations of the algorithm in more clinically relevant conditions have been conducted and show that the algorithm accuracy is 1.3% and therefore is clinically acceptable for tomotherapy.

Algorithms↗

PubMed1999

Dose measurements compared with Monte Carlo simulations of narrow 6 MV multileaf collimator shaped photon beams.

Small fields where electronic equilibrium is not achieved are becoming increasingly important in clinical practice. These complex situations give rise to problems and inaccuracies in both dosimetry and analytical/empirical dose calculation, and therefore require other than conventional methods. A natural diamond detector and a Markus parallel plate ionization chamber have been selected for clinical dosimetry in 6 MV photon beams. Results of simulations using the Monte Carlo system BEAM/EGS4 to model the beam geometry have been compared with dose measurements. A modification of the existing component module for multileaf collimators (MLCs) allowed the modeling of a linear accelerator SL 25 (Elekta Oncology Systems) equipped with a MLC with curved leaf-ends. A mechanical measurement method with spacer plates and a light-field edge detection technique are described as methods to obtain geometrical data of collimator openings for application in the Monte Carlo system. Generally a good agreement is found between measurements and calculations of depth dose distributions and deviations are typically less than 1%. Calculated lateral dose profiles slightly exceed measured dose distributions near the higher level of the penumbras for a 10x2 cm2 field, but agree well with the measurements for all other cases. The simulations are also able to predict variations of output factors and ratios of output factors as a function of field width and field-offset. The Monte Carlo results demonstrate that qualitative changes in energy spectra are too small to explain these variations and that especially geometrical factors affect the output factors and depth dose curves and profiles.

Biophysical Phenomena↗

PubMed2002

Comparison of characteristics of photon and electron beams generated by Philips/Elekta and Varian linear accelerators.

Commissioning data of the common energy of 6 MV photon beams are analyzed for seven Philips/ Elekta linacs of five different models: SL 75/5, SL 15, SL 25, SLi Precise, and SLi. The observed beam quality %dd(10)x of 67.7% +/- 0.3 agrees with the manufacturer's specification of 67.5% +/- 2% but with a much smaller variation, suggesting the possibility of a more accurate beam quality guideline for acceptance commissioning of these linac models. Field size factors are less uniform, especially for the biggest field size of 40 x 40 cm2, but all agree within 1.1% between the five models. These 6 MV photon beams are also shown to be 0.4 MV harder than the Varian 2100C model. For commissioning electron beams generated by the Philips/Elekta models SL 15, SLi Precise and SLi, guidelines can be found from this work for the following parameters: actual field size at 100 SSD (up to +/- 0.6%) (different from manufacturer specified values at 95 SSD), and virtual source distance (up to +/- 0.7%). Significant differences are seen for R50 (up to 3.7 mm), sigma-theta-x, effective source distance, and cone size factor. However, except for R50 where Varian 2100C datasets are not available for comparison, the differences between the different Philips/Elekta models are comparable to those between the same Varian 2100C model linacs measured by us and Watts.

Electrons↗

PubMed2004

Monte Carlo simulation of the photoneutron field in linac radiotherapy treatments with different collimation systems.

Bremsstrahlung photon beams produced by linac accelerators are currently the most commonly used method of radiotherapy for tumour treatments. When the photon energy exceeds 10 MeV the patient receives an undesired dose due to photoneutron production in the accelerator head. In the last few decades, new sophisticated techniques such as multileaf collimators have been used for a better definition of the target volume. In this case it is crucial to evaluate the photoneutron dose produced after giant dipole resonance (GDR) excitation of the high Z materials (mainly tungsten and lead) constituting the collimator leaves in view of the optimization of the radiotherapy treatment. A Monte Carlo approach has been used to calculate the photoneutron dose arising from the GDR reaction during radiotherapy with energetic photon beams. The simulation has been performed using the code MCNP4B-GN which is based on MCNP4B, but includes a new routine GAMMAN to model photoneutron production. Results for the facility at IRCC (Istituto per la Ricerca e la Cura del Cancro) Candiolo (Turin), which is based on 18 MV x-rays from a Varian Clinac 2300 C/D, are presented for a variety of different collimator configurations.

Humans↗

PubMed1996

The calibration of plane parallel ionisation chambers for the measurement of absorbed dose in electron beams of low to medium energies. Part 1: the NACP chamber.

A study was made of calibrating the NACP plane parallel chamber in electron beams from linear accelerators of a different manufacture with energies, Ep,o' from 4.4 to 19.1 MeV, and also in 4 and 6 MV photon beams as well as a cobalt60 beam. The photon beam measurements were both IN-AIR and IN-PHANTOM. With the exception of the lowest energy electron beam (nominal 5 MeV), the ND values from measurements in the electron beams were within +/- 1% of the average value from the three different methods according to the AAPM TG 39 protocol. The preferred method of calibration of an electron chamber is of course in an electron beam at R100 in water. This can still be done in medium energy electron beams (nominal 7 to 14 MeV) for the NACP chamber with the same degree of accuracy and precision as with AAPM TG 39 methodology. Alternatively the traditional cobalt-60 calibration beam can be replaced by a low energy (4-6MV) photon beam for in-phantom calibrations at 50 mm depth, giving comparable results, and with no more uncertainties than those obtained in electron beams.

Biophysical Phenomena↗

PubMed1992

Computer systems and mechanical tools for stereotactically guided conformation therapy with linear accelerators.

An integrated system for fractionated, stereotactically guided conformation radiotherapy has been developed. The system components are a stereotactic fixation system that can be used each treatment day, a localization, and positioning unit that can be used during x-ray computer tomography, magnetic resonance imaging, positron emission tomography, and radiographical examinations as well as for treatment. Conformal precision radiotherapy is planned with a new three-dimensional treatment planning system (Voxel-Plan-Heidelberg) which comprises, among others options, a three-dimensional image correlation procedure as well as routines for the calculation of coplanar and non-coplanar irradiations with irregularly shaped fields. Two different multi-leaf collimators have been designed for precision radiotherapy in the head and neck region. A manual multi-leaf collimator is used for irradiations with stationary beams or for moving beam treatments with invariable irregularly shaped fields. This collimator system is now being used for patient treatments. The design of a computer controlled multi-leaf collimator unit for multiple fixed field irradiation techniques is discussed. All system components are aimed at conforming dose distributions for fractionated radiotherapy treatments to the target to improve sparing of adjacent normal tissues, and at achieving a sufficient geometrical accuracy in the dose application.

Computer Systems↗

PubMed1994

Linear accelerator radiosurgery of cerebral arteriovenous malformations: current status.

228 patients affected by cerebral arteriovenous malformations (AVMs) underwent linear accelerator radiosurgery. Follow-up ranges from 1 to 100 months (mean 42 months). Complete angiographic obliteration was achieved in 47% of treated patients at one year and 80% at 2 years. 17 haemorrhages were observed after treatment and 6 patients died from them. No bleeding took place after complete angiographic obliteration. 11 patients suffered for radionecrosis. In 6 patients complete recovery was obtained with corticoid medication. The aim of this study is to present our results and to evaluate the effect of irradiation on the risk of bleeding after radiosurgery. Patients were considered at risk in the time lapse after irradiation and before angiographic obliteration or other definitive treatment or death. Patients were followed from the date of radiosurgery and the number of haemorrhages were recorded every six months. In our series the bleeding risk in patients harbouring incompletely obliterated AVMs decreases from 8% in the first year after radiosurgery to 0% starting from the 24th month of the follow-up.

Adolescent↗

PubMed2004

Comparison of electron beam characteristics from multiple accelerators.

PURPOSE: To determine the relationships between electron beam depth dose characteristics, depth of maximum dose (d(max)), depth of 80% dose (d(80)), and depth of 50% dose (d(50)), and the nominal energy designation of electron beams from multiple linear accelerators for the purpose of electron beam treatment planning and quality assurance. METHODS: The Radiological Physics Center Staff, during its on-site dosimetry review visits to institutions participating in clinical trials, measured depth dose characteristics for more than 2000 electron beams. Measurements were performed on Varian, Siemens, and Elekta/Philips accelerators generating beams with nominal energy values ranging from 4-22 MeV. The depth dose data were determined at the nominal source-to-skin distance with the reference cone size in accordance with recommendation of the American Association of Physicists in Medicine Task Group 25 report. RESULTS: The important depth dose characteristics d(max), d(80), and d(50) varied in a predictable fashion when plotted against the true beam quality indicator, R(50). However, d(80) and d(50) values overlapped considerably when plotted against the manufacturers' nominal electron energy values. For a specific nominal electron energy value, the values of d(max), d(80), and d(50) varied by as little as 3 mm for low energy levels to nearly as much as 20 mm for high energies. CONCLUSIONS: The manufacturer's nominal electron energy value does not adequately describe the depth dose characteristics of an electron beam for treatment planning purposes. Clinicians and physicists should determine and use only the specific depth dose data for their clinical beams and not the manufacturer's nominal value.

Electrons↗

PubMed1998

Residual chromatin breaks as biodosimetry for cell killing by carbon ions.

We have studied the relationship between cell killing and the induction of residual chromatin breaks on various human cell lines and primary cultured cells obtained by biopsy from patients irradiated with either X-rays or heavy-ion beams to identify potential bio-marker of radiosensitivity for radiation-induced cell killing. The carbon-ion beams were accelerated with the Heavy Ion Medical Accelerator in Chiba (HIMAC). Six primary cultures obtained by biopsy from 6 patients with carcinoma of the cervix were irradiated with two different mono-LET beams (LET = 13 keV/micrometer, 76 keV/micrometer) and 200kV X rays. Residual chromatin breaks were measured by counting the number of non-rejoining chromatin fragments detected by the premature chromosome condensation (PCC) technique after a 24 hour post-irradiation incubation period. The induction rate of residual chromatin breaks per cell per Gy was the highest for 76 keV/micrometer beams on all of the cells. Our results indicated that cell which was more sensitive to the cell killing was similarly more susceptible to induction of residual chromatin breaks. Furthermore there is a good correlation between these two end points in various cell lines and primary cultured cells. This suggests that the detection of residual chromatin breaks by the PCC technique may be useful as a predictive assay of tumor response to cancer radiotherapy.

Biomarkers↗

PubMed2005

Radiation impact caused by activation of air from the future GSI accelerator facility fair.

The Gesellschaft für Schwerionenforschung in Darmstadt is planning a new accelerator Facility for Antiproton and Ion Research (FAIR). Two future experimental areas are regarded to be the most decisive points concerning the activation of air. One is the area for the production of antiprotons. A second crucial experimental area is the so-called Super Fragment Separator. The production of radioactive isotopes in air is calculated using the residual nuclei option of the Monte Carlo program FLUKA. The results are compared with the data for the activation of air given by Sullivan and in IAEA report 283. The resulting effective dose is calculated using a program package from the German Federal Office for Radiation Protection, the Bundesamt für Stranlenschutz. The results demonstrate that a direct emission of the total radioactivity produced into the air will probably conflict with the limits of the German Radiation Protection Ordinance. Special measures have to be planned in order to reduce the amount of radioactivity released into the air.

Air↗

PubMed2005

Spectral discrimination of Cerenkov radiation in scintillating dosimeters.

Radiation therapy accelerators require highly accurate dose deposition and the output must be monitored frequently and regularly. Ionization chambers are the primary tool for this control, but their size, their high voltage needed, and the correction needed for electrons make them unsuitable for use during patient treatment. We have developed a small (1-mm-diam and 1-mm-long active part), flexible, and water-equivalent dosimeter. It is suitable for photon and electron beams without corrections, and performs on line dose measurements. This detector is based on only one scintillating fiber and a CCD camera. A new signal processing is used to remove the effect of Cerenkov radiation background, which only requires a preliminary calibration. Central-axis depth-dose distribution comparisons have been achieved with standard ionization chambers, over a range from 8 to 25 MV photons and from 6 to 21 MeV electrons in order to validate this calibration. Results show a very good agreement, with less than 1% difference between the two detectors.

Calibration↗